[1P-0523] In vivo assessment of antisense oligonucleotides targeting Serine/Arginine Repetitive Matrix 4(SRRM4) abnormally expressed in Small Cell Lung Cancer(SCLC)
small cell lung cancer (SCLC), antisense oligonucleotide (ASO), Serine/Arginine Repetitive Matrix 4 (SRRM4), cancer therapy, oncology
This archive has moved to the member page of The Molecular Biology Society of Japan.
Members can access the abstracts via links at the member page of the sites.
Please feel free to contact the journal offices for any inquiries.